The role of nephrologists in the management of small renal masses

Renal cell carcinoma (RCC) is the most common malignancy seen in the nephrology clinic, yet most nephrologists have inadequate knowledge of current treatment options. Here we discuss RCC presentation and therapies, including potential renal adverse effects, and highlight the need for involvement of nephrologists in the multidisciplinary management of this disease.

  • Subscribe to Nature Reviews Nephrology for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int. 61, 2201–2209 (2002).

  2. 2.

    et al. The nephrologist's tumor: basic biology and management of renal cell carcinoma. J. Am. Soc. Nephrol. 27, 2227–2237 (2016).

  3. 3.

    , , & Screening for acquired cystic kidney disease: a decision analytic perspective. Kidney Int. 48, 207–219 (1995).

  4. 4.

    et al. Renal mass and localized renal cancer: AUA guideline. J. Urol. 198, 520–529 (2017).

  5. 5.

    et al. Trends of acute kidney injury after radical or partial nephrectomy for renal cell carcinoma. Urol. Oncol. 34, 293.e1–293.e10 (2016).

  6. 6.

    , , , & Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. Eur. Urol. 65, 372–377 (2014).

Download references


R.H.W.'s work is supported by NIH grant 1R01DK107416-01A1 and by a grant from Dialysis Clinics Incorporated.

Author information


  1. Division of Kidney Disease and Hypertension, Warren Alpert Medical School of Brown University, Providence, RI, USA.

    • Susie L. Hu
  2. Division of Nephrology, University of California, Davis, CA, USA.

    • Robert H. Weiss
  3. Medical Service, VA Northern California Health Care System, Sacramento, CA, USA.

    • Robert H. Weiss


  1. Search for Susie L. Hu in:

  2. Search for Robert H. Weiss in:

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Susie L. Hu or Robert H. Weiss.